The IL-6/JAK/STAT signaling pathway is involved in the pathogenesis of various inflammatory and autoimmune diseases, and JAK inhibitors are emerging as promising new therapeutics for the treatment of autoimmune diseases40. Here, SOAT1 is linked to autoimmune disease.